Last updated: December 30, 2023
Sponsor: Tianjin Huanhu Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Thrombosis
Cardiac Ischemia
Treatment
Mechanical Thrombectomy
Clinical Study ID
NCT06200753
TJHH-2023-WM28
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;
- Presenting beyond 24 hours from last known well;
- Ischemic stroke confirmed by head CT or MRI;
- Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotidartery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACAA1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCAP1/P2);
- Patients receiving either endovascular therapy or best medical treatment.
Exclusion
Exclusion Criteria:
• Presence of any forms of cerebral hemorrhage on CT/MR at admission.
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Mechanical Thrombectomy
Phase:
Study Start date:
January 01, 2018
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
Tianjin Huanhu Hospital
Tianjin, Tianjin 300070
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.